RxDoctor Payments Data

Jill Nelson, MD

Dermatology · Omaha, NENPI 1164531158

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,625 of the $3,270 with a category attached, or 80.3%. Pfizer accounts for 84.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,756 and has fallen 96.7% since, to $92 in 2025.

$3,270in general payments, 2019–2025

Across 32 payments — averaging $102.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$3K
  • E.r. Squibb & Sons, L.L.C.$120
  • AbbVie$95
  • Amgen$53
  • Novartis$37
  • Galderma Laboratories, L.p.$33
  • plus $159 from 8 others

What the payments were for

  • Speaking & faculty fees$2,62580%
  • Food & beverage$64520%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,270 in reported general payments places this provider in the 65th percentile of 68 dermatology providers in Nebraska.

See all dermatology providers in Nebraska

Medicare billing

Part B allowed, 2024
$229,779
Medicare patients
727
Services billed
5,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$52,955
Fluorouracil64$4,739
Clobetasol Propionate54$2,826
Metronidazole24$1,535
Fluocinonide35$1,398
Triamcinolone Acetonide155$1,371
Ketoconazole72$1,127
Imiquimod24$860
ValacyclovirValacyclovir Hcl17$721
Hydrocortisone105$721
Mupirocin79$677
Doxycycline Hyclate23$606
Spironolactone27$605
MethotrexateMethotrexate Sodium24$402
Cefdinir19$383

Paid to pharmacies, not to this prescriber.

Other dermatology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →